Term ended Aug 10, 2019 · Medium confidence
20-year base term ended Aug 10, 2019
Held by Novartis AG
Filed May 13, 2003 as application 10/437,802 · Granted Sep 20, 2005
Base term, 20 years from filing
Today
Term ended Aug 10, 2019
1999
2026
Clock starts
Aug 10, 1999
Aug 10, 1999
Term ended
Aug 10, 2019
Aug 10, 2019
Granted
Sep 20, 2005
Sep 20, 2005
base term
after the term ends
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 6,566,344, US 6,569,837, to Aug 10, 2019. The term already ends on or before that date, so the cap shortened nothing.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
52
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Aug 10, 1999, when application 09/371,747, the earliest non-provisional in its chain, was filed (this one was filed May 13, 2003); a parent in its chain could not be resolved (the next row) | Aug 10, 2019 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 6,566,344, US 6,569,837) | resolves to Aug 10, 2019, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Aug 10, 2019 | Medium confidence |
This family
| US 6,596,700 | Lapsed on the fee record Jul 2011 | Jul 2011 |
| US 6,566,344 | Term ended Aug 2019 | Aug 2019 |
| US 6,569,837 | Term ended no later than Oct 2020 | no later than Oct 2020 |
| US 6,787,526 | Lapsed on the fee record Sep 2012 | Sep 2012 |
| US 6,946,450 | this patent Aug 2019 | Aug 2019 |
| US 7,608,600 | In force no later than Sep 2028 | no later than Sep 2028 |
| US 7,662,798 | Lapsed on the fee record Feb 2022 | Feb 2022 |
| Application 11/005,440 | Abandoned not computed | not computed |
8 of 52 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 26, 2014 Reel 32535, frame 402 | Idenix Pharmaceuticals, Inc. | Novartis AG | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 6,566,344, US 6,569,837, ends no earlier than this term, so it caps nothing.
Citations
23
later US patents cite this one
That is above the median of utility patents granted in 2005 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.